The results of our WPMY-1 cell experiments indicate that stromal Dkk-3 can attenuate prostate epithelial cell proliferation, restore normal prostate epithelial architecture (as reflected by the acinar morphogenesis assays) and inhibit prostate cancer cell invasion. Here, DKK3 is linked to prostate cancer.